Regencell Bioscience
RGC
#4692
Rank
NZ$3.78 B
Marketcap
NZ$7.63
Share price
-4.13%
Change (1 day)
-66.87%
Change (1 year)

Market capitalization of Regencell Bioscience (RGC)

Market cap: NZ$3.78 Billion

As of November 2026 Regencell Bioscience has a market cap of NZ$3.78 Billion. This makes Regencell Bioscience the world's 4692th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regencell Bioscience from 2021 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$3.78 B-79.07%
2025NZ$18.06 B15750.34%
2024NZ$0.11 B-47.24%
2023NZ$0.21 B-62.2%
2022NZ$0.57 B-5.46%
2021NZ$0.60 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Regencell Bioscience was reported to be:

NZ$3.78 Billion
by Nasdaq info icon info icon
NZ$3.78 Billion
by CompaniesMarketCap info icon info icon